Despite slightly weaker short-term results, Eli Lilly remains optimistic about its prospects through 2025.
Eli Lilly expects 2025 revenue to be between $58 billion and $61 billion, with the midpoint above analysts' expectations of $58.52 billion.
The company plans to increase production capacity and expects that the marketable doses of glucagon-like peptide-1 will increase by at least 60% in the first half of 2025 compared to the same period in 2024.
In addition, the launch of new drugs Jaypirca®, Ebglyss™, Omvoh® and Kisunla™, as well as new indications for existing drugs and further expansion of Mounjaro in the global market will also drive revenue growth.
REALTY ONE GROUP has been ranked the largest real estate brand for four consecutive years
UNBrokerage once again named to Entrepreneur investor data magazine’s prestigious “Franchise 500 ® ” list for explosive growth and viability as other brands decline
A modern, purpose-driven lifestyle brand and one of the fastest-growing franchises in the world, has been named the No. 1 real estate brand on Entrepreneur magazine's competitive 2025 Franchise 500 ® ranking for the fourth consecutive year, coinciding with the global franchisor's 20th anniversary celebration.
This is the ninth time Realty ONE Group has made the list and has continued to climb in the rankings each year, with its closest real estate competitor currently trailing by nearly 20 spots.
“ Achieving the top spot on this respected ranking for the fourth consecutive year further fuels our drive into 2025 and as we celebrate our 20th anniversary, ” said Kuba Jewgieniew, CEO and founder of Realty ONE Group . He added: “Every year, it is because of testimonials like this and the encouragement from our passionate supporters around the world that real estate professionals and entrepreneurs choose to work with us, hoping to share in our success and become a unique and special part of this industry.”
Eli Lilly is expected to report full quarterly results on
-
- Posts: 211
- Joined: Thu Jan 02, 2025 8:19 am